MEDICAL | COMPOUNDS
Suppliers of medical compounds have developed new materials which enhance safety, performance and compliance, writes Chris Saunders
Meeting
the needs of
The market for medical plastics is entering a new phase of technological and commercial expansion, driven by innovation in biocompatible materials, advanced compounding techniques, and increasing demand. With healthcare systems seeking lighter, safer, and more cost-effective materials, plastics continue to displace traditional materials like metal and glass in a growing number of applications. The global medical plastics market is projected to reach over $90bn by 2033 (according to Grand View Research) as demand increases with the next phase of development likely shaped by three converging forces; sustainability, smart functionality, and increasing regulatory requirements. Americhem’s approach emphasises long-term
material consistency and early design collabora- tion, factors increasingly prioritised by engineering and R&D teams. The company actively engages with OEM partners to co-develop and validate next-generation device applications and reports continued double-digit growth in its healthcare segment, supported by its ISO 13485-certified facilities in the US and Denmark and expansion into China this year. At MD&M West 2026, held at the Anaheim
Convention Centre, California, in February, Amer- ichem showcased five key technologies designed
www.compoundingworld.com
medtech manufacturers
to respond to the technical and regulatory com- plexities facing modern medtech. Among the solutions highlighted were internally lubricated compounds under the EcoLube MD umbrella, which are free from per- and polyfluoroalkyl substances (PFAS), laser marking-ready thermo- plastics that enable high-contrast, permanent part identification, new polymer blends with improved sterilisation and durability, additions to the ColorRx line which help OEMs navigate colour compliance challenges, and nDryve, a PFAS-free, in-melt surface modifier targeting nonwoven applications like surgical gowns and hygiene curtains. “There’s a clear shift happening, material choices
are now deeply tied to sustainability goals, regula- tory scrutiny, and device functionality,” said Matt Miklos, Vice President of Corporate Strategy and M&A at Americhem. “What we’re bringing is not a catalogue, it’s a pipeline of engineered solutions designed to be customised, scaled, and validated in partnership with OEMs who are navigating that complexity every day.” Sabic unveiled several new medical-grade thermoplastics at MD&M West 2026 that also help customers navigate PFAS restrictions. These included new Siltem HU copolymers for use in tubing applications, and internally lubricated LNP
April 2026 | COMPOUNDING WORLD 13
Main image: Sabic’s new LNP ELCRES NPCRX9612U compound is intended for applications such as insulin pumps, diagnostic imaging devices, and monitors
I M
A G E :
S A B I C
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42
